First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study
出版年份 2018 全文链接
标题
First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study
作者
关键词
-
出版物
Stem Cells Translational Medicine
Volume 7, Issue 9, Pages 628-635
出版商
Wiley
发表日期
2018-08-07
DOI
10.1002/sctm.18-0079
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acute or Delayed Systemic Administration of Human Amnion Epithelial Cells Improves Outcomes in Experimental Stroke
- (2018) Megan A. Evans et al. STROKE
- Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair
- (2018) Jean L. Tan et al. Stem Cells Translational Medicine
- Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury
- (2017) Dandan Zhu et al. Stem Cell Research & Therapy
- Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies
- (2017) Sajit Augustine et al. Stem Cells Translational Medicine
- Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial
- (2017) Jessica M. Sun et al. Stem Cells Translational Medicine
- Red blood cell transfusion in newborn infants
- (2017) Robin K Whyte et al. Paediatrics & Child Health
- Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs
- (2017) Jacqueline M. Melville et al. PLoS One
- Adequately Dosed Autologous Cord Blood Infusion Is Associated with Motor Improvement in Children with Cerebral Palsy
- (2016) Jessica Sun et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cell-based therapies for neonatal lung disease
- (2016) Megan O’Reilly et al. CELL AND TISSUE RESEARCH
- Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4
- (2016) Jean L. Tan et al. Stem Cells Translational Medicine
- Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial
- (2015) Richard T. Maziarz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Amnion cell-mediated immune modulation following bleomycin challenge: controlling the regulatory T cell response
- (2015) Jean L Tan et al. Stem Cell Research & Therapy
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
- (2015) Jennifer G Wilson et al. Lancet Respiratory Medicine
- Disrupted lung development and bronchopulmonary dysplasia
- (2014) Christopher D. Baker et al. CURRENT OPINION IN PEDIATRICS
- Cell-based therapies for the preterm infant
- (2014) Dandan Zhu et al. CYTOTHERAPY
- Mesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical Trial
- (2014) Yun Sil Chang et al. JOURNAL OF PEDIATRICS
- Need for Supplemental Oxygen at Discharge in Infants with Bronchopulmonary Dysplasia Is Not Associated with Worse Neurodevelopmental Outcomes at 3 Years Corrected Age
- (2014) Abhay Lodha et al. PLoS One
- Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency
- (2014) Wong Cheng Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia
- (2013) Anita Bhandari et al. SEMINARS IN PERINATOLOGY
- Pre- and Postnatal Transplantation of Fetal Mesenchymal Stem Cells in Osteogenesis Imperfecta: A Two-Center Experience
- (2013) Cecilia Götherström et al. Stem Cells Translational Medicine
- Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep
- (2011) Patricia Vosdoganes et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The new bronchopulmonary dysplasia
- (2010) Alan H Jobe CURRENT OPINION IN PEDIATRICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started